Terms: = Head and neck cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
179 results:
1. Applying Machine Learning for Enhanced MicroRNA Analysis: A Companion Risk Tool for Oral Squamous Cell Carcinoma in Standard Care Incisional Biopsy.
Pruthi N; Yap T; Moore C; Cirillo N; McCullough MJ
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672474
[TBL] [Abstract] [Full Text] [Related]
2. HM_ADET: a hybrid model for automatic detection of eyelid tumors based on photographic images.
Jiang J; Liu H; He L; Pei M; Lin T; Yang H; Yang J; Gong J; Wei X; Zhu M; Wu G; Li Z
Biomed Eng Online; 2024 Feb; 23(1):25. PubMed ID: 38419078
[TBL] [Abstract] [Full Text] [Related]
3. Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy.
Chen Y; Chen C; Peng H; Lin S; Pan J; Zheng H; Zong J; Lin C
Sci Rep; 2024 Feb; 14(1):3950. PubMed ID: 38366057
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasound microflow patterns help in distinguishing malignant from benign thyroid nodules.
Li W; Gao L; Du Y; Wang Y; Yang X; Wang H; Li J
Cancer Imaging; 2024 Jan; 24(1):18. PubMed ID: 38268031
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
Pan XB; Lu Y; Wei YS; Yao DS
BMC Cancer; 2024 Jan; 24(1):106. PubMed ID: 38238689
[TBL] [Abstract] [Full Text] [Related]
6. A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced head and neck Squamous Cell Carcinoma.
Ngamphaiboon N; Pattaranutaporn P; Lukerak S; Siripoon T; Jinawath A; Arsa L; Shantavasinkul PC; Taonam N; Trachu N; Jinawath N; Kositwattanarerk A; Sananmuang T; Jiarpinitnun C
Clin Cancer Res; 2024 Jan; 30(2):294-303. PubMed ID: 37982827
[TBL] [Abstract] [Full Text] [Related]
7. GABA regulates the proliferation and apoptosis of head and neck squamous cell carcinoma cells by promoting the expression of ccnd2 and BCL2L1.
Luo K; Zhao X; Shan Y; Wang X; Xu Y; Chen M; Wang Q; Song Y
Life Sci; 2023 Dec; 334():122191. PubMed ID: 37866807
[TBL] [Abstract] [Full Text] [Related]
8. Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma.
Zhong X; Li L; Yin J; Chen Y; Xin X; Yu L; Tang Y; Zhang J; Li J
Cancer Imaging; 2023 Oct; 23(1):98. PubMed ID: 37828560
[TBL] [Abstract] [Full Text] [Related]
9. Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study.
Li K; Zhang S; Hu Y; Cai A; Ao Y; Gong J; Liang M; Yang S; Chen X; Li M; Tian J; Shan H
Ann Surg Oncol; 2023 Dec; 30(13):8231-8243. PubMed ID: 37755566
[TBL] [Abstract] [Full Text] [Related]
10. Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
Guo J; He Y; Lin C; Jiang Q; Xing HW; Zhang YC; Shen GZ; Lin HX; Guo L; Yang Q
Oral Oncol; 2023 Nov; 146():106574. PubMed ID: 37741017
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
Li Y; Gao X; Guo T; Liu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
[TBL] [Abstract] [Full Text] [Related]
12. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
14. Ultrasonography-based radiomics and computer-aided diagnosis in thyroid nodule management: performance comparison and clinical strategy optimization.
Xia M; Song F; Zhao Y; Xie Y; Wen Y; Zhou P
Front Endocrinol (Lausanne); 2023; 14():1140816. PubMed ID: 37251675
[TBL] [Abstract] [Full Text] [Related]
15. Repeated steroid injection and polyglycolic acid shielding for prevention of refractory esophageal stricture.
Sakaguchi Y; Tsuji Y; Sato J; Kubota D; Obata M; Cho R; Nagao S; Miura Y; Ohki D; Mizutani H; Yakabi S; Kakushima N; Niimi K; Fujishiro M
Surg Endosc; 2023 Aug; 37(8):6267-6277. PubMed ID: 37193890
[TBL] [Abstract] [Full Text] [Related]
16. The validation and clinical significance of LPCAT1 down-regulation in acute myeloid leukemia.
Chen Q; Xu Z; Lin J; Deng Z; Qian J; Qian W
Mol Biol Rep; 2023 Jun; 50(6):4955-4963. PubMed ID: 37079124
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of CT enhancement degree in lymph node metastasis of papillary thyroid cancer: A comparison of enhancement, ratio, and difference.
Zhu J; Tian M; Zhang T; Zhu H; Wei P; Han Z
Front Endocrinol (Lausanne); 2023; 14():1103434. PubMed ID: 37033256
[TBL] [Abstract] [Full Text] [Related]
18. Trends in the incidence of head and neck cancer: A nationwide population-based study.
Yang TH; Xirasagar S; Cheng YF; Chen CS; Chang WP; Lin HC
Oral Oncol; 2023 May; 140():106391. PubMed ID: 37030023
[TBL] [Abstract] [Full Text] [Related]
19. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract] [Full Text] [Related]
20. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
[TBL] [Abstract] [Full Text] [Related]
[Next]
